This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Inscripta, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Brian Chaikind: Innovator in Nucleic Acid Editing
Introduction
Brian Chaikind is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid editing. His innovative work has the potential to advance genetic research and therapeutic applications.
Latest Patents
Brian Chaikind holds a patent for a groundbreaking invention titled "Dual strand nucleic acid-guided nickase editing." This patent provides compositions of matter, methods, and instruments for nucleic acid-guided nickase/reverse transcriptase fusion enzyme editing of nucleic acids in live mammalian cells. This technology represents a significant advancement in the ability to edit genetic material with precision.
Career Highlights
Chaikind is currently employed at Inscripta, Inc., a company that focuses on innovative solutions in the field of genetic engineering. His work at Inscripta has allowed him to collaborate with other leading scientists and contribute to cutting-edge research in nucleic acid technologies.
Collaborations
One of his notable coworkers is Aamir Mir, with whom he collaborates on various projects related to nucleic acid editing and genetic engineering.
Conclusion
Brian Chaikind's contributions to the field of nucleic acid editing are noteworthy and have the potential to impact various applications in genetics and biotechnology. His innovative spirit and dedication to research continue to drive advancements in this important area of science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile